NCT04268966View on ClinicalTrials.gov

An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Ebola Virus Disease
Interventions
DRUG

Brincidofovir

Sponsors
All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

Jazz Pharmaceuticals

INDUSTRY